Reduction in facial hyperpigmentation after treatment with a combination of topical niacinamide and tranexamic acid: a randomized, double-blind, vehicle-controlled trial

Skin Res Technol. 2014 May;20(2):208-12. doi: 10.1111/srt.12107. Epub 2013 Sep 5.

Abstract

Background: Facial hyperpigmentation occurs in multiple conditions. In addition, many Asian women desire a lighter skin color. Thus, there is a need for the development of skin lightening agents, and niacinamide and tranexamic acid (TXA) are promising candidates.

Objective: To assess the effectiveness of a combination of niacinamide and TXA as a topical moisturizing formulation for treatment of irregular facial pigmentation.

Materials and methods: A total of 42 Korean women (age range: 30-60 years) who were not pregnant, nursing, or undergoing any concurrent therapy were enrolled in this study for 8 weeks. Subjects used a twice-daily regimen of either a moisturizing cream containing 2% niacinamide + 2% TXA (test formulation; n = 21) or cream vehicles (vehicle control; n = 21) in addition to an assigned sunscreen each morning. Pigmentation was measured objectively using a mexameter and chromameter, in addition to physicians' assessment using clinical photographs.

Results: The niacinamide + TXA formulation regimen was significantly (P < 0.05) more effective than the vehicle control formulation regimen in reducing the appearance of pigmentation.

Conclusion: A formulation containing the combination of niacinamide + TXA reduced the appearance of irregular pigmentation, providing an effect beyond that achieved with sunscreen.

Keywords: facial hyperpigmentation; niacinamide; tranexamic acid.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adult
  • Antifibrinolytic Agents / administration & dosage
  • Delayed-Action Preparations / administration & dosage*
  • Dermatologic Agents / administration & dosage
  • Double-Blind Method
  • Drug Combinations
  • Emollients / therapeutic use
  • Facial Dermatoses / drug therapy*
  • Facial Dermatoses / pathology*
  • Female
  • Humans
  • Hyperpigmentation / drug therapy*
  • Hyperpigmentation / pathology*
  • Middle Aged
  • Niacinamide / administration & dosage
  • Skin Cream / therapeutic use*
  • Tranexamic Acid / administration & dosage*
  • Treatment Outcome
  • Vitamin B Complex / administration & dosage

Substances

  • Antifibrinolytic Agents
  • Delayed-Action Preparations
  • Dermatologic Agents
  • Drug Combinations
  • Emollients
  • Vitamin B Complex
  • Niacinamide
  • Tranexamic Acid